본문 바로가기 · Skip to content
Root InsideROOT INSIDENEWS
Stock fact card· KR · 028300 · as of 2026-10-13

HLB

Not investment advice · For research purposes only; not a solicitation or an offer of any financial product. Past statistics do not indicate future outcomes. Facts from filings and public sources; not investment advice. No valuation estimate, direction or trading levels are provided.

← All cards

① Fact table

Values as filed · consolidated / separate basis per year · no interpretation

Financial facts by year (as filed)
Item20212022202320242025Unit
매출액69,825,991,454179,707,913,11242,900,561,19668,125,727,34784,172,574,224KRW
영업이익-101,018,424,284-74,664,893,059-125,024,740,610-118,516,152,929-104,217,336,541KRW
당기순이익-98,125,465,674-78,158,868,867-189,079,377,012-91,980,166,746-220,500,871,611KRW
자본총계435,957,350,662637,937,266,405523,885,541,075576,572,200,387418,457,232,961KRW
부채총계231,507,461,398268,287,104,470169,475,199,911235,310,995,214435,763,869,963KRW
부채비율(자체 계산: 부채총계 ÷ 자본총계 × 100, 자본 0 이하면 비움, 같은 해 같은 기준)· in house53.1042.0632.3540.81104.14%
Statement basisConsolidatedConsolidatedConsolidatedConsolidatedConsolidated

Source: dart_fnltt · Computed in house · card as of 2026-10-13 · Filing date per year: not on the card (see the filing timeline below) · 'in house' marks items computed from the values above

② Profitability breakdown

Arithmetic on the fact table only · same year, same basis · '—' where a value is missing or the denominator is 0 or below · in each panel the bar height maps the span from the most negative to the largest positive value onto the panel height · no interpretation attached

Operating margin (%)operating income ÷ revenue × 100
-144.72021cons.-41.52022cons.-291.42023cons.-174.02024cons.-123.82025cons.
ROE (%)net income ÷ year-end total equity × 100
-22.52021cons.-12.32022cons.-36.12023cons.-16.02024cons.-52.72025cons.
Debt-to-equity (%)total liabilities ÷ total equity × 100
53.12021cons.42.12022cons.32.32023cons.40.82024cons.104.12025cons.

Source: computed in house from the fact table · card as of 2026-10-13

③ My own calculation

A simple residual-income formula. You enter the assumptions; only the base equity is filled in from the filing. The result is computed from your assumptions and is not a figure this site publishes.

V = B₀ + (ROE − r) × B₀ ÷ (1 + r − ω)

the long-run ROE you assume
the annual return you require
0 = gone after a year · 1 = lasts forever
filled with the 2025 total equity as filed — editable

Fill in all four boxes to compute. The site fills in nothing but the base equity.

Computed in this browser only; nothing you type is sent or stored.

Two-trading-day statistical range· target 2026-10-15
Base close 2026-10-13
44,000
80%
39,681.01 ~ 49,122.85
90%
37,999.52 ~ 52,241.84
Ledger row
f8cdff4b…

Source: fsc_stock_price · published 2026-10-14T11:05:08+09:00 · No direction implied

Prospective recordunknownn = 0days missed 0

No day scored yet — no basis for a hit rate.

Filing timeline
  1. 2026-10-12
    Filing title as filed기업설명회(IR)개최 original ↗
    Source: dart_disclosure
  2. 2026-10-12
    Filing title as filed기타경영사항(자율공시) (HLB 간암 1차 치료제(리보세라닙,캄렐리주맙 병용요법) FDA에 재승인 서류 제출) original ↗
    Source: dart_disclosure
  3. 2026-09-08
    Filing title as filed전환사채(해외전환사채포함)발행후만기전사채취득 original ↗
    Source: dart_disclosure
  4. 2026-09-07
    Filing title as filed주식등의대량보유상황보고서(약식) original ↗
    Source: dart_disclosure
  5. 2026-08-28
    Filing title as filed전환가액의조정 original ↗
    Source: dart_disclosure
  6. 2026-08-20
    Filing title as filed주식등의대량보유상황보고서(일반) original ↗
    Source: dart_disclosure
  7. 2026-08-20
    Filing title as filed임원ㆍ주요주주특정증권등소유상황보고서 original ↗
    Source: dart_disclosure
  8. 2026-08-19
    Filing title as filed증권발행결과(자율공시) original ↗
    Source: dart_disclosure
  9. 2026-08-14
    Filing title as filed파생상품거래손실발생 original ↗
    Source: dart_disclosure
  10. 2026-08-14
    Filing title as filed반기보고서 (2026.06) original ↗
    Source: dart_disclosure
  11. 2026-08-05
    Filing title as filed주요사항보고서(전환사채권발행결정) original ↗
    Source: dart_disclosure
  12. 2026-08-04
    Filing title as filed주식등의대량보유상황보고서(약식) original ↗
    Source: dart_disclosure
  13. 2026-07-27
    Filing title as filed지속가능경영보고서등관련사항(자율공시) original ↗
    Source: dart_disclosure
  14. 2026-07-16
    Filing title as filed전환가액의조정 original ↗
    Source: dart_disclosure
  15. 2026-07-16
    Filing title as filed주식등의대량보유상황보고서(일반) original ↗
    Source: dart_disclosure
  16. 2026-07-15
    Filing title as filed전환가액의조정 original ↗
    Source: dart_disclosure
  17. 2026-07-10
    Filing title as filed기타경영사항(자율공시) (HLB 간암 1차 치료제(리보세라닙,캄렐리주맙 병용요법)FDA로부터 보완요구서한(CRL,Complete Response Letter)수령) original ↗
    Source: dart_disclosure
  18. 2026-07-08
    Filing title as filed기업설명회(IR)개최 original ↗
    Source: dart_disclosure
  19. 2026-06-30
    Filing title as filed기타시장안내(약명및영문명) (영문상호) original ↗
    Source: dart_disclosure
  20. 2026-06-29
    Filing title as filed기업설명회(IR)개최 original ↗
    Source: dart_disclosure
AI accuracy boundary
LayerBadgenNote
rangeunknown080%·90% 범위의 전향 적중 기록(목표일 개장 전 박제 → 종가 공표 뒤 채점)
fair_value제공 안 함0판별력 미확인 — 싣지 않음
direction제공 안 함0판별력 미확인 — 싣지 않음
trade_levels제공 안 함0판별력 미확인 — 싣지 않음
Valuation estimatenot provided—Not published: no demonstrated discriminative power
Direction (up or down)not provided—Not published: no demonstrated discriminative power
Trading levelsnot provided—Not published: no demonstrated discriminative power

Why this?

Do not put personal data in the question. It is sent to an external AI processor to compose the answer.0/300

Checking…